| | |
| UCB's next generation drugs take over after blockbuster expiry Sunday, Oct 28, 2012 11:39 PM PDT BRUSSELS (Reuters) - Belgian pharmaceuticals group UCB said on Monday that sales of its three new main products had for the first time overtaken those of its expiring blockbuster epilepsy treatment Keppra and retained its full-year guidance. UCB, which makes drugs targeted at diseases of the immune and central nervous systems, said on Monday sales of Cimzia, Neupro and Vimpat rose 50 percent to 665 million euros over the first nine months and were now treating about 382,000 patients. UCB said it was on course to reach its goal of 1. ... Full Story | Top |
| New test to improve HIV diagnosis in poor countries Sunday, Oct 28, 2012 10:07 PM PDT LONDON (Reuters) - Scientists have come up with a test for the virus that causes AIDS that is ten times more sensitive and a fraction of the cost of existing methods, offering the promise of better diagnosis and treatment in the developing world. The test uses nanotechnology to give a result that can be seen with the naked eye by turning a sample red or blue, according to research from scientists at Imperial College in London published in the journal Nature Nanotechnology. ... Full Story | Top |
| Six new cases reported in meningitis outbreak Sunday, Oct 28, 2012 07:56 PM PDT  (Reuters) - Six new cases of fungal meningitis have been reported in an outbreak tied to contaminated steroid injections that has led to 25 deaths in the United States, the Centers for Disease Control and Prevention said on Saturday. The CDC reported three new cases in Florida, two in Ohio and one in Indiana, raising the total number of meningitis cases attributed to the tainted steroid to 337 in 18 states. This type of meningitis cannot be spread person-to-person. ... Full Story | Top |
| U.S. regulator needs new authority over compounding pharmacies: report Sunday, Oct 28, 2012 07:56 PM PDT WASHINGTON (Reuters) - The U.S. Food and Drug Administration's power to regulate compounded drugs similar to those linked to a deadly meningitis outbreak is legally nonbinding and lacks the authority of stringent standards imposed on drug manufacturers, according to a congressional report released on Sunday. The report, compiled by the staff of U.S. ... Full Story | Top |
| Massachusetts closes third pharmacy since meningitis outbreak Sunday, Oct 28, 2012 06:03 PM PDT BOSTON (Reuters) - Massachusetts regulators shut down a pharmacy on Sunday after a surprise inspection raised concerns about the sterility of its drugs, in the third such closure since a deadly meningitis outbreak caused by contaminated drugs from another pharmacy in the state. The latest pharmacy to be closed, Infusion Resource, is not affiliated with New England Compounding Center, the company linked to the outbreak, officials said. ... Full Story | Top |
| Trans fats raise cholesterol, not blood sugar: study Sunday, Oct 28, 2012 05:47 PM PDT (Reuters) - Although much-criticized trans fats raise levels of "bad" cholesterol, they don't appear to have a lasting impact on blood sugar levels, according to a U.S. study. Researchers, writing in The American Journal of Clinical Nutrition, found that both blood sugar and insulin, the hormone that keeps blood sugar levels in check, were similar regardless of how much trans fat people ate. The link between trans fats and high cholesterol levels is widely accepted, but there has been a lack of clarity on the effect on blood sugar control, which is involved in diabetes. ... Full Story | Top |
| Plant compounds tied to less stomach cancer in women: study Sunday, Oct 28, 2012 05:20 PM PDT (Reuters) - Getting a moderate amount of plant substances called flavonoids through food may be linked to a lower stomach cancer risk in women - but not in men, according to a European study. The researchers, writing in the American Journal of Clinical Nutrition, found that women with the highest intake of flavonoids were half as likely to develop the disease as women who had the smallest intake. ... Full Story | Top |
| Analysis: Employees to face healthcare sticker shock Sunday, Oct 28, 2012 10:46 AM PDT NEW YORK (Reuters) - Visit to New York City orthopedist: $223. One X-ray: $50. One follow-up magnetic resonance imaging test: $766. Total bill for checking out that aching shoulder: $1,039 - all to be paid by the patient, rather than the insurer. Healthcare has gone retail. Over the next 18 months, between one quarter and one half of Americans who get insurance coverage through their employers will pay more of their doctor bills themselves as companies roll out healthcare plans with higher deductibles, benefits consultants say. The result: sticker shock. ... Full Story | Top |
| South Africa's Zuma drops suit over rape cartoon Sunday, Oct 28, 2012 06:34 AM PDT  JOHANNESBURG (Reuters) - South African President Jacob Zuma intends to drop a four-year-old lawsuit claiming nearly $600,000 in damages from a cartoonist who depicted him poised to rape "Lady Justice", his office said on Sunday. The Sunday Times, named as a defendant in the case, also said it had reached agreement with Zuma's lawyers for the suit and all claims to be ended. "The president ... ... Full Story | Top |
| IBA signs $40 million U.S. cancer facility deal Sunday, Oct 28, 2012 05:54 AM PDT BRUSSELS (Reuters) - Belgian cancer treatment equipment maker IBA said it has signed a $40 million deal for the installation of a treatment facility in Louisiana. The treatment room, which will receive its first patients in early 2014, will use a system designed by Dutch group Philips, which will allow patients to select comforting ambient sound and lighting before starting the therapy. The installation in Shreveport in northern Louisiana is the first such project to be realized with Philips, IBA said on Sunday. (Reporting By Robert-Jan Bartunek; Editing by Hans-Juergen Peters) Full Story | Top |
|
No comments:
Post a Comment